Deokchol Parish
Family · Henderson, NVNPI 1841885142
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 77 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 22 manufacturers, the largest accounting for just 14.6% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $957, more than ten times the $28 reported in 2022.
Across 77 payments — averaging $19.24 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$216
- Lilly USA, LLC$208
- Antares Pharma, Inc.$172
- Novo Nordisk$151
- Pfizer$144
- Intra-sana Laboratories$112
- plus $479 from 16 others
What the payments were for
- Food & beverage$1,482100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 11 | $216 |
| Lilly USA, LLC | 7 | $208 |
| Antares Pharma, Inc. | 19 | $172 |
| Novo Nordisk | 6 | $151 |
| Pfizer | 7 | $144 |
| Intra-sana Laboratories | 1 | $112 |
| Amgen | 5 | $109 |
| AbbVie | 3 | $53 |
| Corcept Therapeutics | 2 | $38 |
| Bayer | 2 | $31 |
| Sumitomo Pharma America, Inc. | 2 | $31 |
| Exact Sciences | 2 | $30 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $28 |
| Gilead | 1 | $25 |
| Novartis | 1 | $24 |
| Inspire Medical Systems, Inc. | 1 | $22 |
| GSK | 1 | $15 |
| Dexcom, Inc. | 1 | $15 |
| Kowa Pharmaceuticals America, Inc. | 1 | $15 |
| Daiichi Sankyo Inc. | 1 | $14 |
| Merz North America, Inc. | 1 | $14 |
| Acadia Pharmaceuticals Inc | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Reltone 200 Mg$112
- GLYCATE$112
- Reltone 400 Mg$112
How this compares
$1,482 in reported general payments places this provider in the 75th percentile of 1,501 family providers in Nevada.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Atorvastatin Calcium | 12 | $86 |
Paid to pharmacies, not to this prescriber.
Other family in Henderson
- Kristy SolisHenderson$23K
- Joseph LauHenderson$18K
- Judith YuHenderson$14K
- Daniel Sam AciertoHenderson$11K
- Reiko TapiaHenderson$10K
- Francis TorresHenderson$8K
- Hollie TylerLas Vegas$118K
- John PhoenixLas Vegas$107K
- Jon FaillaLas Vegas$74K
- Alex LapasaranLas Vegas$50K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.